{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:00:15Z","timestamp":1790852415623,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.rceng.2026.502596","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:13:02Z","timestamp":1781107982000},"page":"502596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sulfonylureas and fracture risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"226","author":[{"given":"L.","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2026.502596_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.rceng.2026.502596_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.25106","article-title":"Type 2 diabetes and fracture risk in older women","volume":"7","author":"Zoulakis","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.rceng.2026.502596_bib0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.rceng.2026.502596_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11914-007-0025-x","article-title":"Diabetes, fracture, and bone fragility","volume":"5","author":"Schwartz","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.rceng.2026.502596_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7608964","article-title":"Pathophysiology and management of type 2 diabetes mellitus bone fragility","volume":"2020","author":"Eller-Vainicher","year":"2020","journal-title":"J Diabetes Res"},{"issue":"9","key":"10.1016\/j.rceng.2026.502596_bib0030","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc14-0398","article-title":"Effect of exenatide, sitagliptin, or glimepiride on \u03b2-cell secretory capacity in early type 2 diabetes","volume":"37","author":"Gudipaty","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.rceng.2026.502596_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/2230-8210.163171","article-title":"Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: a consensus statement","volume":"19","author":"Kalra","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.rceng.2026.502596_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.rceng.2026.502596_bib0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/dc22-1584","article-title":"Concomitant use of sulfonylureas and \u03b2-blockers and the risk of severe hypoglycemia among patients with type 2 diabetes: a population-based cohort study","volume":"46","author":"Dimakos","year":"2023","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.rceng.2026.502596_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11914-014-0202-7","article-title":"Diabetes, collagen, and bone quality","volume":"12","author":"Saito","year":"2014","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"10.1016\/j.rceng.2026.502596_bib0055","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00125-012-2668-0","article-title":"Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs","volume":"55","author":"Colhoun","year":"2012","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.rceng.2026.502596_bib0060","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: the MrOS study","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.rceng.2026.502596_bib0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4093\/dmj.2012.36.2.144","article-title":"Fracture incidence and risk of osteoporosis in female type 2 diabetic patients in Korea","volume":"36","author":"Jung","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.rceng.2026.502596_bib0070","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.rceng.2026.502596_bib0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"10.1016\/j.rceng.2026.502596_bib0080","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.rceng.2026.502596_bib0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.rceng.2026.502596_bib0090","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2015-4180","article-title":"Does sitagliptin affect the rate of osteoporotic fractures in type 2 diabetes? Population-based cohort study","volume":"101","author":"Majumdar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.rceng.2026.502596_bib0095","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00198-016-3595-6","article-title":"Risk of fractures and diabetes medications: a nationwide cohort study","volume":"27","author":"Choi","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.rceng.2026.502596_bib0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bone.2016.11.026","article-title":"Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes","volume":"95","author":"Starup-Linde","year":"2017","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.rceng.2026.502596_bib0105","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00198-017-4021-4","article-title":"Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study","volume":"28","author":"Hung","year":"2017","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.rceng.2026.502596_bib0110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2337\/dc17-1525","article-title":"Analysis of fractures in patients with type 2 diabetes treated with empagliflozin in pooled data from placebo-controlled trials and a head-to-head study versus glimepiride","volume":"41","author":"Kohler","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.rceng.2026.502596_bib0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/dom.14254","article-title":"Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: a subgroup analysis of the randomized CAROLINA trial","volume":"23","author":"Espeland","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.rceng.2026.502596_bib0120","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2147\/DMSO.S339331","article-title":"Increased frequency of severe hypoglycemia with the modified-release gliclazide compared to glimepiride in diabetic older adults; Propensity score-adjusted analysis","volume":"15","author":"Fouad Algendy","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"8","key":"10.1016\/j.rceng.2026.502596_bib0125","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s40520-020-01736-4","article-title":"Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study","volume":"33","author":"Tao","year":"2021","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"10.1016\/j.rceng.2026.502596_bib0130","first-page":"335","article-title":"Hypoglycemia with insulin and sulfonylureas","volume":"66","author":"Kolman","year":"2020","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.rceng.2026.502596_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568026620666191224141617","article-title":"Mechanisms and characteristics of sulfonylureas and glinides","volume":"20","author":"Lv","year":"2020","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"10.1016\/j.rceng.2026.502596_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2024.100357","article-title":"Characteristics of fragility hip fracture-related falls in the older adults: a systematic review","volume":"28","author":"Lim","year":"2024","journal-title":"J Nutr Health Aging"},{"issue":"11","key":"10.1016\/j.rceng.2026.502596_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112243","article-title":"Glimepiride promotes osteogenic differentiation in rat osteoblasts via the PI3K\/Akt\/eNOS pathway in a high glucose microenvironment","volume":"9","author":"Ma","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.rceng.2026.502596_bib0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1S","key":"10.1016\/j.rceng.2026.502596_bib0155","article-title":"Treatment of osteoporotic vertebral fractures","volume":"107","author":"Prost","year":"2021","journal-title":"Orthop Traumatol Surg Res"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887426001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887426001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:49:14Z","timestamp":1790851754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887426001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2254887426001141"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2026.502596","relation":{},"ISSN":["2254-8874"],"issn-type":[{"value":"2254-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfonylureas and fracture risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2026.502596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2026.502596","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502596"}}